Keyphrases
Alemtuzumab
100%
Antithymocyte Globulin
100%
Campath-1H
14%
Cost Consideration
14%
Cost-conscious
14%
Graft Rejection
14%
Grafting Ratio
28%
Immunosuppression
14%
Immunosuppression Regimen
14%
Induction Agents
14%
Induction Immunosuppression
14%
Infectious Complications
14%
Kaplan-Meier Analysis
14%
Long-stay Patients
28%
Maintenance Immunotherapy
100%
Maintenance Therapy
14%
Patient Survival
14%
Patient Survival Rate
14%
Prednisone
100%
Rejection Rate
28%
Renal Allograft Function
14%
Sequential Study
14%
Simultaneous Pancreas-kidney Transplantation
100%
Single Center
14%
Sirolimus
28%
Steroid-free
14%
T Cells
14%
Tacrolimus
28%
Thymoglobulin
14%
Transplantation
14%
Viral Infectious
14%
Immunology and Microbiology
Alemtuzumab
100%
Allograft
12%
Anti-Thymocyte Globulin
100%
Immunology
12%
Immunosuppression
37%
Immunotherapy
100%
Kidney Transplantation
100%
Pancreas
100%
Prednisone
100%
Sirolimus
25%
Survival Rate
12%
T Cell
12%
Tacrolimus
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alemtuzumab
100%
Immunotherapy
100%
Infectious Complication
12%
Prednisone
100%
Rapamycin
25%
Survival Rate
12%
Tacrolimus
25%
Thymocyte Antibody
100%